Chimerix Ownership
| CMRX Stock | USD 8.47 0.01 0.12% |
Shares in Circulation | First Issued 2012-03-31 | Previous Quarter 89.6 M | Current Value 89.7 M | Avarage Shares Outstanding 54.8 M | Quarterly Volatility 25.1 M |
Chimerix |
Chimerix Stock Ownership Analysis
About 53.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.94. Chimerix had not issued any dividends in recent years. Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people. For more info on Chimerix please contact Michael MBA at 919 806 1074 or go to https://www.chimerix.com.Besides selling stocks to institutional investors, Chimerix also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Chimerix's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Chimerix's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Chimerix Quarterly Liabilities And Stockholders Equity |
|
Chimerix Insider Trades History
About 7.0% of Chimerix are currently held by insiders. Unlike Chimerix's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Chimerix's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Chimerix's insider trades
Chimerix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Chimerix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Chimerix backward and forwards among themselves. Chimerix's institutional investor refers to the entity that pools money to purchase Chimerix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Geode Capital Management, Llc | 2024-12-31 | 836.7 K | Renaissance Technologies Corp | 2024-12-31 | 820.3 K | Assenagon Asset Management Sa | 2024-12-31 | 817.7 K | Blackrock Inc | 2024-12-31 | 814.8 K | Peapod Lane Capital Llc | 2024-12-31 | 754.6 K | Citadel Advisors Llc | 2024-12-31 | 729.3 K | Northern Trust Corp | 2024-12-31 | 549.8 K | Goldman Sachs Group Inc | 2024-12-31 | 497.2 K | Connor Clark & Lunn Inv Mgmt Ltd | 2024-12-31 | 429.5 K | Ra Capital Management, Llc | 2024-12-31 | 8.8 M | Vanguard Group Inc | 2024-12-31 | 4 M |
Chimerix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chimerix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chimerix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Chimerix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Chimerix Outstanding Bonds
Chimerix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Chimerix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Chimerix bonds can be classified according to their maturity, which is the date when Chimerix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Chimerix Corporate Filings
| 6th of March 2025 Other Reports | ViewVerify | |
8K | 5th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 14th of February 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.